141 related articles for article (PubMed ID: 12168081)
1. Impact of topotecan-based chemotherapy on the immune system of advanced ovarian cancer patients: an immunophenotypic study.
Ferrari S; Rovati B; Cucca L; Scarabelli C; Presti M; Beccaria C; Collovà E; Porta C; Danova M
Oncol Rep; 2002; 9(5):1107-13. PubMed ID: 12168081
[TBL] [Abstract][Full Text] [Related]
2. Reference values for peripheral blood lymphocyte phenotypes applicable to the healthy adult population in Switzerland.
Bisset LR; Lung TL; Kaelin M; Ludwig E; Dubs RW
Eur J Haematol; 2004 Mar; 72(3):203-12. PubMed ID: 14962239
[TBL] [Abstract][Full Text] [Related]
3. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.
Ginaldi L; De Martinis M; D'Ostilio A; Marini L; Loreto F; Modesti M; Quaglino D
Am J Hematol; 2001 Jun; 67(2):63-72. PubMed ID: 11343377
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of lymphocyte subsets after peripheral blood stem cell transplantation: two-color flow cytometric analysis.
Ashihara E; Shimazaki C; Yamagata N; Hirata T; Okawa K; Oku N; Goto H; Inaba T; Fujita N; Nakagawa M
Bone Marrow Transplant; 1994 Apr; 13(4):377-81. PubMed ID: 7912603
[TBL] [Abstract][Full Text] [Related]
5. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
6. [Phase II clinical study of topotecan hydrochloride in patients with recurrent advanced ovarian cancer].
Li JD; Guan ZZ; Liu JH; Xin XY; Cui Y; Huang CJ; Liu FY; Song L; Bian ML; Zhou QH
Ai Zheng; 2002 Apr; 21(4):416-20. PubMed ID: 12452024
[TBL] [Abstract][Full Text] [Related]
7. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer.
Gordon AN; Tonda M; Sun S; Rackoff W;
Gynecol Oncol; 2004 Oct; 95(1):1-8. PubMed ID: 15385103
[TBL] [Abstract][Full Text] [Related]
9. Topotecan versus treosulfan, an alkylating agent, in patients with epithelial ovarian cancer and relapse within 12 months following 1st-line platinum/paclitaxel chemotherapy. A prospectively randomized phase III trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR).
Meier W; du Bois A; Reuss A; Kuhn W; Olbricht S; Gropp M; Richter B; Lück HJ; Kimmig R; Pfisterer J
Gynecol Oncol; 2009 Aug; 114(2):199-205. PubMed ID: 19446314
[TBL] [Abstract][Full Text] [Related]
10. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly.
Provinciali M; Moresi R; Donnini A; Lisa RM
Gerontology; 2009; 55(3):314-21. PubMed ID: 19190395
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte recovery in advanced ovarian cancer patients after high-dose chemotherapy and peripheral blood stem cell plus growth factor support: clinical implications.
Ferrandina G; Pierelli L; Perillo A; Rutella S; Ludovisi M; Leone G; Mancuso S; Scambia G
Clin Cancer Res; 2003 Jan; 9(1):195-200. PubMed ID: 12538469
[TBL] [Abstract][Full Text] [Related]
12. [Effect of granulocyte colony stimulating factor (G-CSF) on peripheral blood leukocytes and lymphocytes in patients with chemotherapy-induced leukopenia].
Böhme M; Schmidt D; Radke J; Morenz J; Weise W
Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):670-4. PubMed ID: 7531660
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
Hudnall SD; Patel J; Schwab H; Martinez J
Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
[TBL] [Abstract][Full Text] [Related]
14. Quality of life evaluations in patients with ovarian cancer during chemotherapy treatment.
Le T; Leis A; Pahwa P; Wright K; Ali K; Reeder B; Hopkins L; Fung MF
Gynecol Oncol; 2004 Mar; 92(3):839-44. PubMed ID: 14984950
[TBL] [Abstract][Full Text] [Related]
15. Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer.
Chiara S; Tognoni A; Pastrone I; Tomasello L; Brema F; Di Costanzo G; Folco U; Pronzato P;
Gynecol Oncol; 2004 May; 93(2):474-8. PubMed ID: 15099965
[TBL] [Abstract][Full Text] [Related]
16. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer.
Kormosh N; Laktionov K; Antoshechkina M
Phytother Res; 2006 May; 20(5):424-5. PubMed ID: 16619374
[TBL] [Abstract][Full Text] [Related]
17. Reduction of CD45RA isoform expression and decrease in CD4 and CD8 receptor density in lymphocytes of patients with primary biliary cirrhosis.
Musialik J; Michalkiewicz J; Petelenz M; Mazurek U; Mazur W; Madaliński K; Gonciarz Z
Scand J Gastroenterol; 2003 Apr; 38(4):421-6. PubMed ID: 12739715
[TBL] [Abstract][Full Text] [Related]
18. Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome.
Daniel V; Naujokat C; Sadeghi M; Weimer R; Renner F; Yildiz S; Opelz G
Transpl Int; 2008 Jul; 21(7):646-60. PubMed ID: 18298587
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
[TBL] [Abstract][Full Text] [Related]
20. [Selected lymphocyte subsets in Lime borreliosis: a preliminary study].
Zajkowska JM; Hermanowska-Szpakowicz T; Kasprzycka E
Pol Merkur Lekarski; 1999 May; 6(35):259-62. PubMed ID: 10437395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
